427
Participants
Start Date
March 30, 2020
Primary Completion Date
April 30, 2026
Study Completion Date
April 30, 2026
ELOCTA
Extended half-life factor VIII product
University Hospital Brno, Brno
University Hospital Ostrava, Ostrava
Dept. of Pediatric Haematology and Oncology, University Hospital Motol, Prague
Lastehaigla, Tallinn (Tallinn Children´s Hospital), Tallinn
The North Estonia Medical Centre Hematoloogiakeskus, Regionalhaigla, Tallinn
Helsinki University Central Hospital, New Children Hospital, Helsinki
Turku University Central Hospital, Paediatric and adolescent haematology and oncology clinic, Turku
Charité-Universitätsmedizin Berlin Campus Virchow Klinikum, Berlin
Universitätsklinikum Bonn AöR, Institut für Experimentelle Hämatologie und Transfusionsmedizin, Bonn
Hämostaseologie/Hämophiliezentrum, Medizinische Klinik 2 Institut für Transfusionsmedizin, Universitätsklinikum, Frankfurt
Universitätsklinikum Frankfurt - Klinik für Kinder- und Jugendmedizin, Frankfurt
Universitätsklinikum Hamburg-Eppendorf (UKE), Hamburg
Medizinische Hochschule Hannover, Hanover
Werlhof-Institut für Hämostaseologie GmbH, Hanover
SRH-Klinikum Heidelberg, Heidelberg
HZRM Hämöphilie Zentrum Rhein Main, Mörfelden-Walldorf
Kinderklinik und Kinderpoliklinik im Dr. von Haunerschen Kinderspital am Universitätsklinikum München, München
Ippokrateio Hospital Thessaloniki (adult department), Thessaloniki
Ippokrateio Hospital Thessaloniki (pediatric department), Thessaloniki
University of Bari Aldo Moro (Centro Emofilia Policlinico - Pediatria U.O.), Bari
AUSL Romagna Centro Emofilia U.O.C., Medicina Trasfusionale Dipartimento Patologia, Clinica Ospedale M. Bufalini, Cesena
Giannina Gaslini Institute, Genova
Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan
University Hospital of Parma, AOUP, Haemophilia Center, Parma
Uo Malattie Emorragiche e Trombotiche Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Universitá Catolica del Sacro Coure, Rome
Azienda Ospedaliera Città della Salute e della Scienza di Torino Regina Margherita, Torino
University Medical Center Groningen/UMCG, Groningen
The Royal Hospital, Muscat
Dr Suliman Al Habib Hospital Riyadh, Riyadh
King Faisal Specialised Hospital, KFSH Riyadh, Children, Riyadh
King Faisal Specialist Hospital KFSH, Adults, Riyadh
Riyadh Military Hospital (P.S.M.C), Riyadh
University Medical Centre Ljubljana Division of Paediatrics, Ljubljana
Hospital de la Santa Creu i Sant Pau, Barcelona
Hospital Vall d'Hebron, Barcelona
Sant Johan De Deu, Barcelona
Hospital Universitario Cruces, Cruces
Hospital Universitario Donostia, Donostia / San Sebastian
Hospital Universitario Carlos Haya, Málaga
Hospital Virgen de la Arrixaca, Murcia
Complejo Hospitalario de Navarra, Navarro
Hospital Universitario Central de Asturias (HUCA), Oviedo
Hospital Universitario Son Espases, Palma de Mallorca
Hospital Universitario Virgen del Rocío, Seville
Hospital Alvaro Cunqueiro, Vigo
Hematologimottagning Sahlgrenska, Gothenburg
Department of Haematology, Oncology and Radiation Physics, Skåne University Hospital Malmö, Malmo
Universitätsklinik für Hämatologie und Hämatologisches Zentrallabor Inselspital, Bern
Service et Laboratoire central d'hématologie, Adults, Lausanne
Zentrum für Labormedizin, Sankt Gallen
Universitätsspital Zürich Klinik für Medizinische Onkologie und Hämatologie, Zurich
East Kent Hospitals University NHS Foundation Trust, Kent Haemophilia and Thrombosis Centre, Kent and Canterbury Hospital, Canterbury
Great Ormond Street Hospital, Royal London Hospital for Integrated Medicine, London
Lead Sponsor
Swedish Orphan Biovitrum
INDUSTRY